Outcomes of treatment with direct-acting antivirals for infection with hepatitis C virus genotypes 1–4 in an ambulatory care setting-Reference-Cited by-同舟云学术

Outcomes of treatment with direct-acting antivirals for infection with hepatitis C virus genotypes 1–4 in an ambulatory care setting

Published:2017-03-01 Issue:5_Supplement_1 Volume:74 Page:S1-S9
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Bach Timothy A.¹,Zaiken Kathy¹

Affiliation:

1. MCPHS University, Boston, MA

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/74/5_Supplement_1/S1/28336959/ajhp00s1.pdf

Reference38 articles.

1. Centers for Disease Control and Prevention. Viral hepatitis—hepatitis C information (2016). www.cdc.gov/hepatitis/hcv/hcvfaq.htm#section1 (accessed 2016 Apr 8).

2. All-cause mortality and progression risks to hepatic decompensation and hepatocellular carcinoma in patients infected with hepatitis C virus;Xu;Clin Infect Dis,2016

3. Hepatitis C treatment outcomes in Australian clinics;Gidding;Med J Aust,2012

4. High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials;Marcellin;Hepatology,2012

5. Evaluated outcomes in patients with chronic hepatitis C;Ashtari;Gastroenterol Hepatol Bed Bench,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing Clinical Pharmacist Specialist to Manage Hepatitis C Virus Patients on Direct-Acting Antiviral Therapy;Journal of Pharmacy Practice;2018-05-21

2. Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation;Scandinavian Journal of Gastroenterology;2018-05-02